3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Leukemia, Myeloid, Acute
11
Myelodysplastic Syndromes
9
Lymphoma
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Leukemia
6
Hematologic Neoplasms
6
Neuroblastoma
4
Neoplasms
4
Lymphoma, Non-Hodgkin
4
Leukemia, Biphenotypic, Acute
4
Leukemia, B-Cell
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Melanoma
3
Leukemia, Lymphoid
3
Hodgkin Disease
3
Hematologic Diseases
3
Sarcoma
2
Rhabdoid Tumor
2
Recurrence
2
Preleukemia
2
Precancerous Conditions
2
Osteosarcoma
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms by Histologic Type
2
Multiple Myeloma
2
Lymphoproliferative Disorders
2
Lymphatic Diseases
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myeloid
2
Interventions
X-Rays
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Temozolomide
2
LY3023414
2
Etoposide
2
thymoglobulin
1
temsirolimus
1
talazoparib
1
olaparib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
amino-acid, glucose, and electrolyte solution
1
Vincristine
1
Vemurafenib
1
Thiotepa
1
Tacrolimus
1
Surgical Procedures, Operative
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Mesna
×
1 year
×
Clear all
No trials found.